Multimodal therapy in metastatic Ewing's sarcoma: an Intergroup Study. 1981

T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard

Multimodal therapy consisting of radiation therapy to all areas of gross disease and intensive combination chemotherapy was administered to 44 patients with Ewing's sarcoma. Seven of these patients had regional disease and the others had clinical evidence of distant metastases. The median duration of time on study for all patients was 75 weeks. A complete response occurred in 31 of the patients and 17 are currently free of disease. Four deaths resulted from complications of therapy; 2 were due to infection and 2 due to adriamycin-related cardiomyopathy.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
March 1983, Cancer,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
September 1983, Human pathology,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
April 1981, Cancer,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
January 1982, The American journal of pediatric hematology/oncology,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
January 1999, Klinische Padiatrie,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
June 1978, Cancer,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
January 1982, Placenta,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
April 1988, Human pathology,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
September 1991, Journal of surgical oncology,
T J Vietti, and E A Gehan, and M E Nesbit, and E O Burgert, and M Pilepich, and M Tefft, and J Kissane, and D J Pritchard
July 2001, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!